Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke

A Clinical Study of Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Chronic Stroke

The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with chronic stroke.

Inclusion Criteria:

• males and females
• above 18 years of age
• diagnosed as stroke by clinical and MRI findings

Exclusion Criteria:

• presence of respiratory distress
• presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/Hepatitis C Virus
• malignancies
• acute medical conditions such as respiratory infection, fever
• hemoglobin less than 8
• bleeding tendency
• bone marrow disorder
• left ventricular ejection fraction < 30%
• pregnancy or breastfeeding